Back to discover
Disease

Hepatitis, Viral, Human

Late-stage therapeutic developmentEmerging research
MeSHHepatitis, Viral, Human
1
Publications
8
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Global burden of liver disease: 2023 update.

Research2023-03-27Journal of hepatology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

7 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
8
All trials
0
Active
4
Late-stage
6
Completed
Late-stage studies

Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines

Phase 4 · Completed · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

A Randomized and Multicenter Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis

Phase 3 · Completed · ANRS, Emerging Infectious Diseases

A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients

Phase 3 · Completed · Biotest Pharmaceuticals Corporation

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)
Recently completed

Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines

Phase 4 · Completed · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients

Phase 3 · Completed · Biotest Pharmaceuticals Corporation

A Randomized and Multicenter Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis

Phase 3 · Completed · ANRS, Emerging Infectious Diseases

An Open Study to Investigate the Effects of Chronic Viral Hepatitis B or C on the Pharmacokinetics of Cholyl-lysyl-fluorescein (NRL972) Before, During and After Standard Treatment.

Phase 2 · Completed · Norgine

An Open Label, Dose Escalation Study of EMZ702 in Combination With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Non-responsive to Prior Therapy With Pegylated Interferon and Ribavirin

Phase 1 · Completed · OPKO Health, Inc.

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Global burden of liver disease: 2023 update.

Journal of hepatology · 2023 · 1,435 cites
Recent publications

Global burden of liver disease: 2023 update.

Journal of hepatology · 2023 · 1,435 cites
Major themes5
  • Carcinoma, Hepatocellular1
  • Hepatitis, Viral, Human1
  • Liver Diseases, Alcoholic1
  • Liver Neoplasms1
  • Non-alcoholic Fatty Liver Disease1
Leading journals1
  • Journal of hepatology1
Leading researchers6
  • Arab JP1
  • Asrani SK1
  • Devarbhavi H1
  • Kamath PS1
  • Nartey YA1
  • Pose E1
Affiliations (unnormalised)6
  • Baylor University Medical Center1
  • Hospital Clinic of Barcelona1
  • Mayo Clinic College of Medicine and Science1
  • School of Medical Sciences1
  • Schulich School of Medicine1
  • St. John's Medical College Hospital1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).

Identifiers
MeSHHepatitis, Viral, Human
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.